Key result
Immunoadsorption improves cardiac function in patients with dilated cardiomyopathy, suggesting a functional role for cardiac autoantibodies in the disease.
Why the study?
Does immunoadsorption improve cardiac function in patients with dilated cardiomyopathy?
Does immunoadsorption improve cardiac function in patients with dilated cardiomyopathy?
This review highlights evidence that immunoadsorption can improve cardiac function in patients with dilated cardiomyopathy, supporting the role of humoral immunity in its pathogenesis.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice; leaves open confirmation of immunoadsorption benefit in randomized trials.
Felix et al. (2001) conducted a review in Dilated cardiomyopathy (DCM). Immunoadsorption was evaluated on Cardiac function. Immunoadsorption improves cardiac function in patients with dilated cardiomyopathy, suggesting a functional role for cardiac autoantibodies in the disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: